background
aim
middl
east
respiratori
syndrom
coronaviru
merscov
rapidli
spread
throughout
middl
east
sinc
discoveri
viru
pose
signific
global
public
health
threat
potenti
devast
effect
studi
recombin
adenoviralbas
vaccin
encod
spike
subunit
merscov
genom
construct
humor
cellular
immun
respons
evalu
mice
mice
immun
initi
intramuscular
inject
boost
week
later
intranas
applic
express
protein
lung
kidney
detect
use
convent
polymeras
chain
reaction
pcr
immunohistochemistri
ihc
target
specif
region
within
subunit
week
first
vaccin
antigenspecif
humor
cellular
immun
respons
evalu
serum
cell
cultur
follow
vitro
stimul
specif
epitop
within
protein
cysslildi
result
protein
express
detect
ihc
kidney
group
week
first
immun
lung
kidney
group
convent
pcr
week
postprim
vaccin
elicit
specif
g
antibodi
respons
detect
sera
vaccin
mice
week
onset
first
immun
signific
increas
amount
cytokin
interleukin
il
signific
decreas
cytokin
splenocyt
cell
cultur
vaccin
group
compar
control
group
result
studi
suggest
recombin
adenoviru
vaccin
encod
subunit
merscov
elicit
potenti
protect
antigenspecif
humor
cellular
immun
respons
mice
studi
demonstr
promis
vaccin
control
andor
prevent
merscov
infect
human
middl
east
respiratori
syndrom
coronaviru
merscov
newli
emerg
human
coronaviru
discov
saudi
arabian
man
follow
discoveri
mani
case
identifi
differ
region
arabian
peninsula
worldwid
thereaft
recent
outbreak
occur
june
south
korea
link
south
korean
man
recent
travel
middl
east
infect
rapidli
spread
person
close
contact
hospit
within
month
mani
case
report
hospit
nonhospit
person
south
korea
diseas
show
high
mortal
rate
reach
higher
sever
acut
respiratori
syndrom
coronaviru
sarscov
outbreak
coronavirus
belong
subfamili
coronavirina
within
famili
coronavirida
order
nidoviral
five
human
coronavirus
identifi
sarscov
merscov
lineag
c
betacoronavirus
includ
bat
coronavirus
give
primit
impress
regard
origin
viru
detect
merscov
neutral
antibodi
sera
dromedari
camel
shed
light
role
camel
possibl
anim
reservoir
may
transmit
viru
human
inde
research
isol
merscov
strain
camel
barn
infect
owner
saudi
arabia
thu
provid
evid
potenti
airborn
direct
contact
transmiss
viru
camel
human
sever
attempt
develop
protect
vaccin
merscov
research
around
world
focus
spike
protein
main
target
vaccin
develop
merscov
spike
protein
merscov
attach
host
dipeptidyl
receptor
express
sever
type
human
cell
mani
studi
publish
sinc
suggest
vaccin
model
construct
base
spike
protein
receptorbind
domain
rbd
region
elicit
strong
protect
immun
respons
vitro
vivo
recombin
adenovir
vector
vaccin
one
effect
vaccin
show
interest
result
sarscov
outbreak
sinc
sever
studi
publish
differ
viral
vector
eg
adenovirus
vaccinia
viru
use
develop
recombin
vaccin
candid
base
full
spike
gene
part
test
abil
produc
protect
immun
merscov
infect
howev
investig
need
suggest
vaccin
includ
test
abil
elicit
neutral
antibodi
differ
anim
model
stimul
innat
adapt
immun
respons
correspond
cytokin
chemokin
profil
distribut
within
host
safeti
durat
profil
studi
recombin
adenoviralbas
vaccin
encod
spike
subunit
merscov
genom
construct
humor
cellular
immun
respons
evalu
mice
procedur
perform
studi
approv
jordan
univers
scienc
technolog
anim
use
care
committe
recombin
human
adenoviru
type
vaccin
design
express
domain
spike
protein
merscov
isol
hu
genbank
access
number
control
cytomegaloviru
cmv
promot
vaccin
construct
laboratori
vector
biolab
gene
deliveri
compani
pa
usa
six
eight
weekold
male
balbc
mice
purchas
anim
hous
jordan
univers
scienc
technolog
irbidjordan
distribut
three
group
replic
manner
anim
first
group
immun
anim
second
group
receiv
vectoronli
adcmv
anim
last
group
serv
control
receiv
phosphatebuff
salin
pb
first
immun
vaccin
inject
intramuscularli
dose
ml
contain
pfu
dosemous
volum
adcmv
pb
use
two
group
booster
dose
carri
week
later
intranas
rout
dose
ml
contain
pfudosemous
experiment
procedur
use
studi
approv
anim
care
use
committe
faculti
veterinari
medicin
irbidjordan
lung
kidney
spleen
tissu
sampl
harvest
mous
group
week
first
immun
part
lung
kidney
preserv
formalin
solut
embed
paraffin
block
immunohistochem
analysi
part
store
polymeras
chain
reaction
pcr
analysi
spleen
tissu
harvest
store
cell
cultur
analysi
blood
sampl
drawn
facial
vein
rout
left
min
room
temperatur
centrifug
rpm
min
collect
sera
store
subsequ
analysi
studi
distribut
recombin
vaccin
total
mg
lung
kidney
tissu
week
postprim
immun
cut
homogen
ml
diethyl
pyrocarbonatetr
water
homogen
sampl
centrifug
rpm
min
supernat
use
extract
extract
perform
use
viral
genespin
rna
extract
kit
intron
biotechnolog
korea
accord
manufactur
instruct
extract
rna
use
cdna
synthesi
revers
transcript
system
promega
madison
wi
usa
accord
manufactur
instruct
cdna
kept
pcr
analysi
dna
templat
construct
vaccin
also
purifi
use
posit
control
experi
heminest
pcr
carri
use
specif
primer
target
specif
sequenc
within
region
shown
tabl
first
pcr
target
bp
sequenc
pcr
mixtur
contain
primer
use
cdna
templat
touchdown
pcr
assay
program
mycycl
thermal
cycler
biorad
laboratori
hercul
ca
usa
follow
condit
min
follow
cycl
min
cycl
min
final
extens
step
min
two
microlit
first
pcr
product
use
templat
second
heminest
pcr
amplifi
bp
product
follow
first
pcr
condit
band
visual
agaros
gel
use
ultraviolet
transillumin
local
protein
express
investig
kidney
lung
tissu
group
week
first
vaccin
ihc
use
rabbitspecif
hrpdab
abc
detect
ihc
kit
abcam
cambridg
uk
adapt
use
antinovel
coronaviru
spike
protein
polyclon
antibodi
sinobiolog
pa
usa
thick
section
formalin
fix
paraffinembed
tissu
cut
load
special
coat
slide
prepar
slide
put
oven
min
follow
min
xylen
solut
deparaffin
section
dri
surround
liquid
blocker
dako
pen
antigen
retriev
pretreat
step
execut
immers
section
reveal
decloak
reagent
biocar
medic
pacheco
ca
usa
heat
microwav
sever
time
min
cool
room
temperatur
min
stain
procedur
carri
follow
manufactur
instruct
abc
kit
elimin
effect
intern
renal
biotin
avidin
appli
sigmaaldrich
st
loui
mo
usa
kidney
section
min
room
temperatur
immunoreact
express
protein
visual
use
light
microscop
differ
magnif
spleen
tissu
group
collect
pool
homogen
obtain
singlecel
suspens
cell
centrifug
min
rpm
pellet
resuspend
roswel
park
memori
institut
medium
rpmi
gibco
grand
island
ny
usa
supplement
fetal
calf
serum
mm
hepe
penicillinstreptomycin
mm
lglutamin
ngml
amphiostat
b
complet
rpmi
cell
suspens
wash
centrifug
describ
earlier
spleen
cell
resuspend
red
blood
cell
lysi
buffer
trisbuff
nh
cl
remov
erythrocyt
cell
group
resuspend
ml
complet
rpmi
plate
plate
triplic
parallel
adjac
well
first
set
sampl
stimul
specif
peptid
epitop
cysslildi
per
well
antigen
defin
highest
potenti
tcell
epitop
total
eight
potenti
epitop
within
rbd
region
subunit
spike
protein
merscov
genom
expect
display
interact
maximum
number
major
histocompat
complex
mhc
class
molecul
show
highest
peak
bcell
antigen
plot
second
set
sampl
stimul
nonspecif
stimul
phytohemagglutinin
confirm
viabil
product
cultur
cell
third
set
sampl
stimul
control
set
cell
incub
roundbottom
microtit
plate
co
cultur
media
collect
h
sampl
centrifug
min
rpm
supernat
store
cytokin
analysi
pellet
store
realtim
rt
pcr
analysi
detect
measur
specif
igg
achiev
use
semiquantit
antimerscov
elisa
igg
euroimmun
ag
luebeck
germani
slight
modif
use
univers
enzym
conjug
antimous
iggconjug
hrp
abl
detect
mous
igg
antibodi
instead
human
igg
antibodi
microtit
plate
precoat
purifi
antigen
merscov
mous
dilut
serum
sampl
incub
well
three
experiment
group
adcmv
pb
min
room
temperatur
follow
manufactur
instruct
color
intens
measur
use
elisa
plate
reader
biotek
winooski
vt
usa
cell
cultur
supernat
stimul
correspond
nonstimul
sampl
three
group
test
level
mous
cytokin
week
postprim
use
quantit
sandwich
enzym
immunoassay
techniqu
quantikin
elisa
mous
cytokin
immunoassay
minneapoli
mn
usa
accord
manufactur
instruct
rel
quantif
mous
normal
housekeep
gene
cell
cultur
yield
stimul
group
collect
pellet
cell
cultur
use
extract
total
rna
use
sv
total
rna
isol
system
promega
accord
manufactur
instruct
extract
kit
dnase
incub
step
elimin
dna
sampl
isol
rna
store
rtpcr
analysi
rna
concentr
adjust
use
te
buffer
purifi
rna
use
templat
produc
cdna
use
revers
transcript
system
promega
kit
rel
rtpcr
assay
perform
determin
mrna
express
level
mous
cell
cultur
fold
chang
calcul
use
method
normal
specif
primer
set
use
shown
tabl
extract
rna
use
templat
pcr
reaction
mixtur
compos
forward
revers
primer
powerup
sypr
green
master
mix
appli
biosystem
foster
citi
ca
usa
nucleasefre
water
rtpcr
condit
program
rotor
geneq
qiagen
hilden
germani
follow
min
min
follow
cycl
min
melt
step
data
elisa
fold
chang
express
mean
standard
deviat
oneway
anova
ttest
use
compar
differ
valu
group
use
openepi
softwar
emori
univers
usa
paramet
differ
consid
statist
signific
p
paramet
differ
indic
small
letter
label
within
group
differ
letter
indic
signific
differ
p
distribut
express
subunit
merscov
spike
protein
mice
tissu
detect
week
post
first
immun
kidney
lung
vaccin
group
control
group
use
convent
pcr
use
ihc
protein
express
detect
cytoplasm
proxim
tubul
epithelium
vaccin
mice
week
post
first
immun
control
group
express
detect
lung
tissu
either
vaccin
control
group
signific
level
p
specif
igg
antibodi
detect
mice
sera
vaccin
group
week
postprim
combin
result
week
reveal
igg
antibodi
respons
significantli
higher
p
vaccin
group
control
group
avail
level
mous
cytokin
week
first
vaccin
cell
cultur
supernat
stimul
correspond
nonstimul
sampl
three
group
test
sandwich
elisa
assay
mice
cytokin
product
adcmv
pb
group
combin
express
collect
one
group
control
group
due
nonsignific
differ
shown
across
time
point
two
group
therefor
level
cytokin
two
test
time
point
week
first
vaccin
also
combin
express
one
unit
regardless
vitro
stimul
product
significantli
p
higher
vaccin
group
compar
control
group
adcmv
pb
test
time
point
term
product
vitro
stimul
mersspecif
peptid
cysslildi
result
signific
p
upregul
product
compar
antigenstimul
nonstimul
cell
cultur
vaccin
group
although
signific
differ
product
control
group
vaccin
group
nonstimul
cell
cultur
antigenspecif
stimul
clearli
reveal
higher
product
cytokin
control
group
vaccin
group
level
product
p
addit
vitro
stimul
mer
specif
peptid
cysslildi
result
signific
upregul
product
cytokin
control
group
antigen
stimul
result
signific
decreas
product
vaccin
group
p
week
post
first
immun
fold
chang
gene
express
significantli
higher
control
group
adcmv
pb
p
howev
promin
increas
gene
express
week
postprim
vaccin
adcmv
group
compar
week
p
express
slightli
higher
statist
signific
vaccin
group
compar
adcmv
group
week
p
signific
chang
p
gene
express
observ
adcmv
group
week
signific
chang
observ
vaccin
group
time
point
studi
potenti
protect
humor
cellular
immun
respons
elicit
mice
immun
use
recombin
adenoviralbas
vaccin
encod
subunit
merscov
spike
gene
sever
studi
publish
construct
similar
vaccin
merscov
test
abil
induc
product
neutral
antibodi
immun
system
compon
result
studi
encourag
show
vitro
regardless
vitro
stimul
product
significantli
p
higher
vaccin
group
admiddl
east
respiratori
syndrom
mer
compar
control
group
adcytomegaloviru
phosphatebuff
salin
test
time
point
vitro
antigenspecif
stimul
result
signific
upregul
product
compar
antigenstimul
nonstimul
cell
cultur
vaccin
group
vitro
stimul
use
mersspecif
peptid
cysslildi
result
signific
upregul
product
control
group
antigen
stimul
result
signific
decreas
product
vaccin
group
ns
nonantigen
stimul
ag
antigenstimul
differ
letter
mean
significantli
differ
p
avail
vaccin
may
promis
prevent
global
threat
merscov
infect
howev
safeti
efficaci
vaccin
still
confirm
confirm
protein
respons
product
neutral
antibodi
subunit
contain
rbd
bind
host
receptor
also
known
induc
product
specif
neutral
antibodi
sever
studi
support
role
domain
elicit
protect
immun
merscov
challeng
studi
abl
demonstr
distribut
express
protein
vaccin
group
control
group
adcmv
pb
detect
truncat
proteinencod
segment
kidney
lung
tissu
follow
vaccin
use
convent
pcr
ihc
find
support
abil
vaccin
candid
distribut
effect
within
host
tissu
express
target
protein
establish
express
multipl
cell
type
human
bodi
includ
cell
kidney
lung
howev
n
glycoprotein
glycoprotein
mer
target
investig
merscov
local
use
ihc
n
glycoprotein
clearli
present
lung
tissu
follow
mer
exposur
fact
current
studi
consid
pioneer
given
use
glycoprotein
express
viral
distribut
tissu
therefor
express
protein
kidney
tissu
lung
might
use
explain
previou
vitro
experi
found
cytopath
effect
merscov
infect
insid
primari
human
kidney
cell
primari
human
bronchial
epitheli
cell
recent
studi
adenovir
vector
enhanc
green
fluoresc
protein
adenovir
vector
mer
mice
experi
intramuscular
intranas
inject
support
find
construct
abl
reach
lung
tissu
protein
express
lung
tissu
howev
gene
detect
lung
tissu
convent
pcr
ihc
indic
investig
necessari
regard
level
intens
express
tissu
addit
studi
also
need
explor
protein
express
tissu
liver
intestin
given
express
tissu
studi
signific
serum
level
igg
antibodi
vaccin
group
control
group
adcmv
pb
similar
result
shown
previous
sarscov
vaccin
strong
abil
elicit
igg
antibodi
respons
result
present
studi
also
support
find
recent
public
appli
similar
vector
vaccin
construct
helper
immun
respons
known
domin
immun
respons
case
intracellular
pathogen
virus
bacteria
helper
immun
respons
domin
immun
respons
case
extracellular
pathogen
allerg
reaction
mani
pathogen
especi
virus
shift
host
immun
respons
toward
domin
respons
evad
cellular
immun
studi
abl
provok
proinflammatori
antiinflammatori
cytokin
releas
respons
elicit
follow
immun
cytokin
repres
respons
upregul
repres
respons
downregul
abl
induc
product
signific
amount
regardless
antigenspecif
stimul
similar
increas
appar
vaccin
anim
respons
specif
vitro
antigen
stimul
mrna
express
detect
earli
week
first
immun
contrast
product
cell
cultur
show
signific
increas
control
anim
antigen
stimul
product
cytokin
significantli
decreas
week
fold
chang
gene
express
significantli
higher
admiddl
east
respiratori
syndrom
mer
group
control
group
adcytomegaloviru
cmv
phosphatebuff
salin
howev
promin
increas
gene
express
week
adcmv
group
compar
week
signific
chang
gene
express
adcmv
group
week
signific
chang
observ
group
time
point
differ
letter
indic
statist
signific
differ
p
vaccin
group
result
demonstr
neither
posit
neg
impact
express
mice
vaccin
mice
receiv
pb
interestingli
signific
increas
gene
express
antigenstimul
cell
cultur
obtain
mice
vaccin
adcmv
week
might
due
abil
adenovirus
elicit
strong
humor
cellular
immun
respons
therefor
conclud
presenc
protein
gene
adenoviru
vector
genom
disturb
immun
stimul
abil
adenoviru
vector
elicit
cytokin
two
studi
shed
light
abil
subunit
specif
abil
rbd
domain
shift
host
immun
respons
toward
demonstr
two
studi
produc
mainli
immun
respons
decreas
produc
mainli
immun
respons
upregul
follow
vaccin
vaccin
candid
truncat
rbd
fuse
fc
portion
human
igg
abl
elicit
isotyp
rel
higher
amount
isotyp
respons
recombin
adenoviru
vector
carri
subunit
whole
gene
also
abl
induc
type
immun
respons
level
detect
earlier
higher
merss
week
postvaccin
week
accordingli
find
lead
domin
toward
cellular
immun
sever
vivo
vitro
studi
reveal
abil
merscov
evad
host
innat
immun
respons
downregul
antigenpres
pathway
proinflammatori
cytokin
sever
merscov
protein
previous
identifi
potent
ifn
antagonist
includ
structur
protein
orf
orf
orf
accessori
protein
addit
comparison
immun
respons
two
mersinfect
patient
one
poor
outcom
die
elev
level
promot
immun
respons
patient
overcam
infect
increas
level
promot
immun
respons
gener
crucial
induc
earli
strong
innat
immun
respons
merscov
infect
save
live
vaccin
candid
abl
induc
product
key
cytokin
activ
lymphocyt
toward
cell
also
indic
upregul
antigenpres
pathway
vaccin
also
trigger
product
involv
respons
may
refer
counter
effect
produc
produc
cell
final
import
clarifi
vitro
antigen
stimul
done
use
specif
peptid
cysslildi
peptid
locat
posit
within
conserv
region
glycoprotein
among
identifi
merscov
strain
select
computer
simul
show
sequenc
highest
b
cell
antigen
plot
abil
form
greatest
number
interact
mhcclass
allel
although
epitop
abl
increas
product
level
vitro
stimul
result
signific
increas
product
signific
decreas
product
vaccin
group
addit
epitop
abl
increas
product
vitro
stimul
adcmv
group
howev
find
enough
prove
claim
epitop
mayb
crucial
role
merscov
pathogenesi
henc
studi
vivo
knockout
experi
conduct
address
role
epitop
merscov
pathogenesi
overal
adenovir
vector
encod
subunit
merscov
genom
promis
vaccin
candid
merscov
infect
clearli
demonstr
recombin
vaccin
distribut
host
tissu
addit
construct
could
induc
product
specif
igg
antibodi
respons
well
immun
respons
evid
increas
level
proinflammatori
cytokin
vaccin
anim
